About Sernova

Sernova Corp., a health sciences company, engages in the research and development activities in the biotechnology sector in Canada. The company focuses on the commercialization of medical technologies. The company is developing a platform technology for various serious disease indications, starting with a treatment for insulin-dependent diabetes, using the Cell Pouch System and its patented Sertolin cell technology. Its major technology is a platform for the transplantation of cells or combinations of cells into humans to treat various serious chronic medical conditions. Target disease applications include Type-1 diabetes, insulin-dependent Type-2 diabetes, Parkinson’s Disease, spinal cord injuries, hemophilia and stem cell transplantation. Production and Services The services the company intends to provide includes manufacture and sale of the Cell Pouch System, which is used for cell implantation. It also may provide services involving isolation and implantation of islets and other cells for transplantation, isolation and implantation of sertoli cells for implantation and immunoprotection of the therapeutic implanted cells and combinations thereof. History The company was formerly known as Pheromone Sciences Corporation and changed its name to Sernova Corp. in 2006.